Method for identifying rifampicin heterogeneity drug resistance of mycobacterium tuberculosis based on fluorescein flow cytometry

A technology of Mycobacterium tuberculosis and flow cytometry, applied in the direction of microorganism-based methods, biochemical equipment and methods, and microorganism measurement/testing, can solve mutations, affect detection accuracy, and reduce the clinical reference value of detection results and other problems to achieve high accuracy and avoid the accumulation of experimental errors

Active Publication Date: 2021-02-23
广州市胸科医院
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the current drug resistance detection technology has become mature, for example, the traditional proportional method DST is a reliable and sensitive method for detecting drug resistance, but to detect and obtain the heterogeneous drug resistance of pathogenic bacteria, the current technology For the case, it must rely on genetic testing technology
However, there are defects in genetic testing that can only detect drug-resistant gene mutations that are clearly related to the phenotype, and cannot identify unspecified drug-resistant genes, which will eventually affect the detection accuracy and reduce the clinical reference value of the test results.
[0005] At present, no other more accurate and convenient technical means have been effectively applied to the detection of heterogeneous drug resistance of Mycobacterium tuberculosis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for identifying rifampicin heterogeneity drug resistance of mycobacterium tuberculosis based on fluorescein flow cytometry
  • Method for identifying rifampicin heterogeneity drug resistance of mycobacterium tuberculosis based on fluorescein flow cytometry
  • Method for identifying rifampicin heterogeneity drug resistance of mycobacterium tuberculosis based on fluorescein flow cytometry

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Embodiment 1 The method for identifying heterogeneous drug resistance of Mycobacterium tuberculosis by flow cytometry based on fluorescein of the present invention

[0043] 1.1 Equipment and materials

[0044] The flow cytometer FACSAriaTM Ⅱ was produced by BD Company in the United States, and the bacterial ultrasonic disperser BACspreaderTM 1100 was produced by Guangdong Tibikang Biotechnology Co., Ltd.; the 300-mesh stainless steel cell filter was purchased from Xiangbo Biotechnology Co., Ltd. Middlebrook 7H10 solid medium and Middlebrook 7H9 liquid medium was purchased from BD Company in the United States, fluorescein diacetate was purchased from LIFE Company in the United States, and PBS (pH 7.4±0.1) was purchased from Hangzhou Gino Biomedical Technology Co., Ltd.

[0045] 1.2 Identification method

[0046] S1. Preparation of working solution:

[0047] Fluorescein diacetate fluorescent dye: take out the stock solution of fluorescein diacetate fluorescent dye, thaw...

Embodiment 2

[0057] Example 2 Using the method of the present invention to detect Rifampicin heterogeneously resistant Mycobacterium tuberculosis

[0058] Take 30 strains of Mycobacterium tuberculosis that have been determined to be heterogeneously resistant to rifampicin and Mycobacterium tuberculosis that are sensitive to rifampicin. Containing rifampicin-resistant Mycobacterium tuberculosis accounted for 0% (that is, containing 100% of sensitive bacteria), 25% (that is, containing 75% of sensitive bacteria), 50% (that is, containing 50% of sensitive bacteria), 75% % (that is, containing 25% of sensitive bacteria) and 100% (that is, containing 0% of sensitive bacteria) bacterial liquid samples.

[0059] According to the operation method of Example 1, the above-mentioned 150 samples of the prepared bacterial liquid were tested according to the method of Example 1. On the 10th and 14th day of treatment with the drug (rifampicin final concentration was 50 μg / mL), the Sampling, staining, te...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of drug sensitivity detection, in particular to a method for identifying rifampicin heterogeneity drug resistance of mycobacterium tuberculosis based on fluoresceinflow cytometry. The method comprises the following steps: S1, a working solution is prepared; S2, analysis bacterial solutions are treated for 10 days or 14 days by using a substitution solution and arifampicin working solution respectively; S3, the treated bacterial solutions are dyed respectively; and S4, the dyed bacterial solutions are detected respectively, an average fluorescence intensityvalue of each bacterial solution is recorded, a sensitivity index of each bacterial solution is calculated, and the sensitivity of each bacterial solution to rifampicin is judged according to the sensitivity index: when the sensitivity index is higher than a critical value, the detected mycobacterium tuberculosis is heterogeneity drug-resistant mycobacterium tuberculosis or drug-resistant mycobacterium tuberculosis, when the sensitivity index is lower than the critical value, the the detected mycobacterium tuberculosis is a sensitive bacterium, and the critical value range is 0.48 or 0.37. Themethod is relatively high in accuracy, a detection result of rifampicin heterogeneity drug resistance of the mycobacterium tuberculosis can be rapidly obtained within 10 days, and the accuracy, sensitivity and specificity are high.

Description

technical field [0001] The invention relates to the field of drug sensitivity detection, in particular to a method for identifying heterogeneous resistance to rifampicin of mycobacterium tuberculosis by flow cytometry based on fluorescein. Background technique [0002] Flow cytometry has the advantages of high throughput, multi-parameters, and high efficiency, and is increasingly used in microbial drug susceptibility testing. The essence of detecting bacterial drug sensitivity is to monitor the activity of bacteria after drug treatment. Flow cytometry reflects the activity of bacteria by monitoring the difference in fluorescence value after the interaction between bacteria and fluorescent dyes in different states. The viability of sensitive bacteria decreases after being treated with antibiotics, while the viability of drug-resistant bacteria does not change. If microorganisms with different vigor or functional states combine with specific fluorescent dyes to emit fluorescen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/18C12R1/32
CPCC12Q1/18G01N2333/35
Inventor 李华刘志辉谢贝杨瑜张言斌刘文
Owner 广州市胸科医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products